Found 39 matching trials
RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL. PHASE2 In this study, newly diagnosed non-elderly patients with Philadelphia chrom...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL PHASE2 Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Show More Location
Department of Hematology, Nanfang Hospital
Learn More & Join Trial
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL PHASE2 Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Show More Location
Department of Hematology, Nanfang Hospital
Learn More & Join Trial
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse PHASE1 This phase I/II trial studies the safety, side effects, and best dose of de...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML NA This study evaluates the efficacy and safety of the combination of idarubic...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial
Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML PHASE3 This research is being done to assess the therapeutic efficacy and safety o...
Show More Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Learn More & Join Trial
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML PHASE3 A randomized,multicenter, open-label Phase III, clinical study is conducted...
Show More Location
the First Affiliated Hospital,College of Medicine,Zhejiang University
Learn More & Join Trial
Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM) PHASE1 To search for a Maximum Tolerated Dose (MTD) for the combination of daratum...
Show More Learn More & Join Trial
Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma PHASE2 The purpose of this real-world study is to evaluate the safety and efficacy...
Show More Location
Zhongda Hospital, Southeast University
Learn More & Join Trial
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML PHASE2 The goal of this clinical trial is to estimate the rate (probability) of co...
Show More Location
First Affiliated Hospital Of University of Science and Technology of China
Learn More & Join Trial